118 related articles for article (PubMed ID: 2318676)
21. DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 group.
Moraes ME; Fernandez-Viña M; Stastny P
Hum Immunol; 1991 Jun; 31(2):139-44. PubMed ID: 2066273
[TBL] [Abstract][Full Text] [Related]
22. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility.
Horn GT; Bugawan TL; Long CM; Erlich HA
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6012-6. PubMed ID: 2842756
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
24. Molecular variation of human major histocompatibility complex DQw3 beta-chains.
So AK; Lindsay J; Bodmer J; Trowsdale J
J Immunol; 1987 Nov; 139(10):3506-11. PubMed ID: 2890689
[TBL] [Abstract][Full Text] [Related]
25. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10.
Bidwell JL; Bidwell EA; Savage DA; Middleton D; Klouda PT; Bradley BA
Transplantation; 1988 Mar; 45(3):640-6. PubMed ID: 2894727
[TBL] [Abstract][Full Text] [Related]
26. RFLP analysis of HLA-DR and -DQ genes and their linkage relationships in the Pacific.
Kohonen-Corish MR; Serjeantson SW
Am J Hum Genet; 1986 Dec; 39(6):751-62. PubMed ID: 2879442
[TBL] [Abstract][Full Text] [Related]
27. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G
Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048
[TBL] [Abstract][Full Text] [Related]
28. Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities.
Reinsmoen NL; Bach FH
Hum Immunol; 1986 Aug; 16(4):329-46. PubMed ID: 2428780
[TBL] [Abstract][Full Text] [Related]
29. DNA sequence analysis and restriction fragment length polymorphism (RFLP) typing of the HLA-DQw2 alleles associated with dermatitis herpetiformis.
Otley CC; Wenstrup RJ; Hall RP
J Invest Dermatol; 1991 Aug; 97(2):318-22. PubMed ID: 1677025
[TBL] [Abstract][Full Text] [Related]
30. Molecular mapping class II polymorphisms in the human major histocompatibility complex. II. DQ beta.
MacMurray AJ; Bell JI; Denney D; Watling D; Foster LS; McDevitt HO
J Immunol; 1987 Jul; 139(2):574-86. PubMed ID: 2885374
[TBL] [Abstract][Full Text] [Related]
31. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus.
Baisch JM; Weeks T; Giles R; Hoover M; Stastny P; Capra JD
N Engl J Med; 1990 Jun; 322(26):1836-41. PubMed ID: 2348836
[TBL] [Abstract][Full Text] [Related]
32. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM.
Erlich HA; Bugawan TL; Scharf S; Nepom GT; Tait B; Griffith RL
Diabetes; 1990 Jan; 39(1):96-103. PubMed ID: 2210066
[TBL] [Abstract][Full Text] [Related]
33. DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics.
Mignot E; Lin X; Kalil J; George C; Singh S; Billiard M; Montplaisir J; Arrigoni J; Guilleminault C; Dement WC
Sleep; 1992 Oct; 15(5):415-22. PubMed ID: 1455124
[TBL] [Abstract][Full Text] [Related]
34. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
35. A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility.
Carcassi C; Trucco G; Trucco M; Contu L
Hum Immunol; 1991 Jul; 31(3):159-64. PubMed ID: 1890017
[TBL] [Abstract][Full Text] [Related]
36. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
[TBL] [Abstract][Full Text] [Related]
37. Molecular complexity of HLA-DQw3: the TA10 determinant is located on a subset of DQw3 beta chains.
Radka SF; Scott RG; Stewart SJ
Hum Immunol; 1987 Apr; 18(4):287-300. PubMed ID: 2437090
[TBL] [Abstract][Full Text] [Related]
38. Sequencing and genetic analysis of a bovine DQB cDNA clone.
Xu A; Clark TJ; Teutsch MR; Schook LB; Lewin HA
Anim Genet; 1991; 22(5):381-98. PubMed ID: 1776708
[TBL] [Abstract][Full Text] [Related]
39. HLA-DQ heterogeneity among HLA-DRw11(5) haplotypes.
Amar A; Mickelson E; Hansen JA; Nepom GT
Tissue Antigens; 1986 Nov; 28(5):278-87. PubMed ID: 2881380
[TBL] [Abstract][Full Text] [Related]
40. HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology.
Carlsson B; Wallin J; Böhme J; Möller E
Hum Immunol; 1987 Oct; 20(2):95-113. PubMed ID: 2890607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
